Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.

#2014
#ARTHRITIS AND RHEUMATISM

PMU Autor*in
Felix Eckstein

Alle Autor*innen
L Stefan Lohmander, Scarlett Hellot, Don Dreher, Eduard F W Krantz, Dawie S Kruger, Ali Guermazi, Felix Eckstein

Fachzeitschrift
ARTHRITIS AND RHEUMATISM

Kurzfassung

Keywords

MRI, QUANTITATIVE ASSESSMENT, INITIATIVE PROGRESSION SUBCOHORT, REGIONAL-ANALYSIS, PLACEBO-CONTROLLED TRIAL, CLINICALLY IMPORTANT DIFFERENCES, FEMOROTIBIAL CARTILAGE LOSS, DOUBLE-BLIND, GLUCOSAMINE SULFATE, PREDICTIVE-VALIDITY